Clinical Improvement of Bullous Pemphigoid with Hyperkeratosis and Palmoplantar Keratoderma in Two Patients Treated with Dupilumab

Acta Derm Venereol. 2024 Oct 10:104:adv41984. doi: 10.2340/actadv.v104.41984.

Authors

Giulia Pascolini¹, Feliciana Mariotti², Anna Pira², Biagio Didona¹, Giovanni Di Zenzo³

Affiliations

¹ Rare Skin Diseases Center, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
² Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
³ Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy. g.dizenzo@idi.it.

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal, Humanized* / therapeutic use
Dermatologic Agents / therapeutic use
Female
Humans
Keratoderma, Palmoplantar* / drug therapy
Male
Pemphigoid, Bullous* / diagnosis
Pemphigoid, Bullous* / drug therapy
Skin / drug effects
Skin / pathology
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
dupilumab
Dermatologic Agents

Grants and funding

Funding sources This article was partially supported by the “Progetto Ricerca Corrente” of the Italian Ministry of Health.